A double-blind, randomized, uncontrolled study to evaluate inhibition of ovulation of two oral estradiol/drospirenone regimens in healthy young female volunteers over a period of 3 treatment cycles.
Phase of Trial: Phase II
Latest Information Update: 10 Jun 2014
At a glance
- Drugs Estradiol/drospirenone (Primary)
- Indications Pregnancy
- Focus Therapeutic Use
- Sponsors Bayer
- 30 Jan 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 24 Sep 2008 Bayer Schering Pharma added as an affiliate as reported by ClinicalTrials.gov.
- 24 Mar 2008 New trial record.